Icon

SYMPROIC (nda208854)- (EQ 0.2MG BASE)

NALDEMEDINE TOSYLATE BDSI
EQ 0.2MG BASE
No No
2033-May-13 2022-Mar-23
None None
None No
SYMPROIC is an opioid antagonist indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 0.2MG BASE ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.